|
PYPL
|
Financial Services |
DZ Bank |
Downgrade
|
Buy
→
Hold
|
—
|
$42.4B
|
$56.13
|
+0.1%
|
+5.0%
|
+2.0%
|
-3.0%
|
+1.0%
|
+1.4%
|
|
PYPL
|
Financial Services |
Argus |
Downgrade
|
Buy
→
Hold
|
—
|
$42.4B
|
$56.13
|
+0.1%
|
+5.0%
|
+2.0%
|
-3.0%
|
+1.0%
|
+1.4%
|
|
BBD
|
Financial Services |
Jefferies |
Downgrade
|
Buy
→
Hold
|
—
|
$37.8B
|
$2.73
|
-1.1%
|
+0.0%
|
+0.7%
|
-1.8%
|
-0.7%
|
+1.5%
|
|
PRU
|
Financial Services |
Raymond James |
Downgrade
|
Strong Buy
→
Market Perform
|
—
|
$35.4B
|
$108.61
|
-1.0%
|
-2.8%
|
+1.6%
|
-1.9%
|
+1.1%
|
+2.7%
|
|
EXPE
|
Consumer Cyclical |
BofA Securities |
Downgrade
|
Buy
→
Neutral
|
—
|
$28.4B
|
$159.47
|
-18.1%
|
-17.8%
|
+1.9%
|
+0.9%
|
-0.0%
|
+2.8%
|
|
ALB
|
Basic Materials |
Citigroup |
Downgrade
|
Buy
→
Neutral
|
—
|
$20.0B
|
$114.33
|
-0.7%
|
+1.3%
|
+3.7%
|
-6.6%
|
+2.0%
|
+2.7%
|
|
EG
|
Financial Services |
Wells Fargo |
Downgrade
|
Overweight
→
Equal Weight
|
—
|
$14.8B
|
$354.56
|
-0.8%
|
-0.2%
|
+2.0%
|
+2.0%
|
+0.8%
|
+0.9%
|
|
LULU
|
Consumer Cyclical |
Exane BNP Paribas |
Downgrade
|
Neutral
→
Underperform
|
—
|
$14.2B
|
$472.98
|
-1.3%
|
-0.6%
|
-0.9%
|
-2.1%
|
+1.0%
|
-0.4%
|
|
ENS
|
Industrials |
Oppenheimer |
Downgrade
|
Outperform
→
Perform
|
—
|
$8.8B
|
$90.87
|
-0.4%
|
-1.0%
|
+0.5%
|
-2.7%
|
+2.8%
|
+1.6%
|
|
ZWS
|
Industrials |
Mizuho |
Downgrade
|
Buy
→
Neutral
|
—
|
$7.9B
|
$33.25
|
-1.8%
|
-3.1%
|
+0.4%
|
-4.3%
|
+2.4%
|
+1.2%
|
|
SYNA
|
Technology |
Craig-Hallum |
Downgrade
|
Buy
→
Hold
|
—
|
$4.9B
|
$110.22
|
-2.9%
|
+1.8%
|
+1.3%
|
-4.9%
|
+2.3%
|
-0.5%
|
|
NVST
|
Healthcare |
Jefferies |
Downgrade
|
Buy
→
Hold
|
—
|
$3.9B
|
$22.44
|
+0.0%
|
-2.2%
|
+3.9%
|
-3.9%
|
+1.1%
|
+1.6%
|
|
ABG
|
Consumer Cyclical |
Craig-Hallum |
Downgrade
|
Buy
→
Hold
|
—
|
$3.6B
|
$206.79
|
-0.5%
|
+4.4%
|
+3.0%
|
-1.8%
|
+1.2%
|
+0.1%
|
|
SPB
|
Consumer Defensive |
Canaccord Genuity |
Downgrade
|
Buy
→
Hold
|
—
|
$1.9B
|
$86.10
|
-0.2%
|
-0.3%
|
+2.2%
|
-3.2%
|
+0.9%
|
+0.2%
|
|
CX
|
Basic Materials |
Barclays |
Downgrade
|
Overweight
→
Equal Weight
|
—
|
$1.8B
|
$7.98
|
-2.4%
|
-4.0%
|
+1.7%
|
-2.4%
|
-0.4%
|
+1.5%
|
|
SYBX
|
Healthcare |
Chardan Capital |
Downgrade
|
Buy
→
Neutral
|
—
|
$8M
|
$3.45
|
-53.3%
|
-48.7%
|
-2.8%
|
+1.2%
|
+2.3%
|
+3.4%
|
|
SYBX
|
Healthcare |
Leerink Partners |
Downgrade
|
Outperform
→
Market Perform
|
—
|
$8M
|
$3.45
|
-53.3%
|
-48.7%
|
-2.8%
|
+1.2%
|
+2.3%
|
+3.4%
|
|
SYBX
|
Healthcare |
HC Wainwright & Co. |
Downgrade
|
Buy
→
Sell
|
—
|
$8M
|
$3.45
|
-53.3%
|
-48.7%
|
-2.8%
|
+1.2%
|
+2.3%
|
+3.4%
|